Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FW37G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,812
Award facts
- Contract value 100% obligated
- $36,812.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $36,812.39 by the Defense Logistics Agency on December 31, 2025, with an ultimate completion date of January 2, 2026. The contract calls for the delivery of Dupixent 300 mg/2 ml pens (2 ml units), a specialty pharmaceutical product used to treat atopic dermatitis, asthma, and other allergic conditions. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 running through December 2026.
This delivery order represents a routine fulfillment under AmerisourceBergen's prime indefinite delivery vehicle, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The DLA Medical Supply Chain relies on such contracts to ensure timely delivery of critical specialty medications to military personnel, veterans, and associated healthcare beneficiaries. AmerisourceBergen's role as a primary pharmaceutical vendor reflects the company's capability to meet federal procurement standards and deliver specialized brand-name medications essential to military medical operations.
Quick answers
Who was awarded contract SPE2DR26FW37G?
SPE2DR26FW37G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26FW37G worth?
The government has obligated $36,812 on SPE2DR26FW37G.
Is contract SPE2DR26FW37G an order under another contract?
Yes. SPE2DR26FW37G is a delivery order under SPE2DR25D3011, an indefinite delivery contract.
Was contract SPE2DR26FW37G competed?
The extent of competition for SPE2DR26FW37G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award